Introduction
============

Pathogenic bacteria have evolved specialized protein secretion systems to transfer a wide array of bacterial proteins into eukaryotic cells, exhibiting an intimate relationship between bacteria and host cells. Historically referred to as type III, IV, and VI secretion systems, distinct types of "nanomachines" are used by pathogenic bacteria to directly inject bacterial proteins, so called "effector proteins," into the host cell cytosol (Galan, [@B23]; Christie et al., [@B11]; Backert and Meyer, [@B6]; Galan and Wolf-Watz, [@B24]; Filloux et al., [@B17]). These effector proteins modulate many cellular processes essential for the establishment of infection, such as actin cytoskeleton rearrangement, vesicular trafficking manipulation, interference of numerous cellular signaling pathways, and escape of host immune systems (Galan, [@B23]; Waterman and Holden, [@B82]; Backert and Meyer, [@B6]; Pukatzki et al., [@B62]). Therefore, it can be said that effector proteins play a key role in the hijacking of host cellular systems by bacteria.

In some cases, effector proteins translocated into host cells by a bacterium display opposing functions on a single host protein. For instance, *Legionella pneumophila* DrrA/SidM and LepB are effector proteins with opposing effects on the host Rab1 GTPase; DrrA functions as a guanine nucleotide exchange factor (GEF), and LepB has GTPase-activating protein (GAP) activity (Machner and Isberg, [@B51], [@B52]; Murata et al., [@B54]; Ingmundson et al., [@B39]). As discussed later in this article, the *Salmonella enterica* serovar Typhimurium effectors SopE and SptP also display GEF and GAP activities, respectively, for the Rho family of GTPases. To conduct opposing functions according to the progressive stages of infection, effector expression, translocation, and activity within host cells must be precisely regulated in a temporal and/or spatial manner.

Ubiquitin is a small protein of 76 amino acids and is conserved among all eukaryotic organisms (Goldstein et al., [@B28]). Ubiquitination is a process that involves the covalent addition of one or several ubiquitins onto a target protein, and is one of the essential post-translational modifications of eukaryotic proteins (Hershko and Ciechanover, [@B33]). The process involves at least three distinct types of enzymes: E1 activating enzymes, E2 conjugation enzymes, and E3 ubiquitin ligases (Hershko et al., [@B34]). E3 ubiquitin ligases are responsible for substrate specificity by directly interacting with target proteins. They are a large and diverse group of proteins and are subclassified into two major types depending on the presence of distinct motifs: the really interesting new gene (RING)/U-box domain and the homologous to E6-associated protein C terminus (HECT) domain (Pavletich, [@B60]; Ardley and Robinson, [@B4]).

The conjugation of a single ubiquitin, known as monoubiquitination, can trigger an alteration in the activity and/or localization of target proteins, and is involved in many cellular processes including membrane trafficking, endocytosis, DNA repair, and transcription regulation (Haglund and Dikic, [@B29]). The fate of proteins possessing four or more chains of ubiquitin is determined by the linkage pattern of the polyubiquitin chains. Polyubiquitinated proteins with Lys-48-linked chains are commonly targeted for 26S proteasome-dependent degradation, whereas Lys-63-linked polyubiquitination is involved in a wide range of cellular processes (Thrower et al., [@B79]; Haglund and Dikic, [@B29]).

Previous studies have established that many pathogenic bacteria use the host ubiquitin system to establish infection and to evade the host immune system (Angot et al., [@B3]; Rytkonen and Holden, [@B67]; Hicks and Galan, [@B35]). Furthermore, evidence indicates that ubiquitination of effector proteins plays a critical role in the temporal or spatial regulation of proteins within the host cytoplasm. Here, we review three examples of ubiquitin-mediated spatial or temporal regulation of bacterial effectors: (1) *Legionella* metaeffector LubX, which functions as an E3 ubiquitin ligase on another effector SidH, leading to proteasomal degradation; (2) *Salmonella* effectors SopE and SptP, both of which are subjected to proteasomal degradation with distinct half-lives; and (3) *Salmonella* effector SopB, the cellular localization of which is regulated by ubiquitination of the protein.

Bacterial Effector Proteins Mimicking Eukaryotic E3 Ligases
===========================================================

Recent studies have revealed that many bacterial effectors have E3 ubiquitin ligase activity. SopA, a *Salmonella* Typhimurium effector, is an example of a bacterial HECT-type E3 ubiquitin ligase and is involved in the host inflammatory response following *Salmonella* infection (Zhang et al., [@B85]; Diao et al., [@B13]). SopA itself is reported to be ubiquitinated by the host E3 ubiquitin ligase HsRMA1 (Zhang et al., [@B84]). A homolog of SopA, the enterohemorrhagic *Escherichia coli* (EHEC) O157 effector protein NleL, was recently characterized by the same group (Lin et al., [@B49]), showing that it has E3 ligase activity and shares structural similarity with SopA.

There are some examples of bacterial RING/U-box-type E3 ligases. The *Pseudomonas syringae* effector AvrPtoB has no detectable sequence similarity to eukaryotic E3 ligases, but structural studies demonstrated that AvrPtoB has higher-order structural similarity to the U-box domain (Janjusevic et al., [@B41]). AvrPtoB suppresses programmed cell death in infected plants depending on E3 ligase activity (Abramovitch et al., [@B2], [@B1]). The host targets of AvrPtoB have been identified. Several kinases important in plant immunity, including tomato Fen kinase (Rosebrock et al., [@B65]), plant pattern-recognition receptor FLS2 (Gohre et al., [@B27]), and LysM receptor kinase CERK1 (Gimenez-Ibanez et al., [@B25]), were subjected to AvrPtoB-mediated polyubiquitination, resulting in proteasomal degradation. Recent studies also revealed that *E. coli* O157 NleG effectors have higher-order, but not primary, structural similarity to the RING/U-box domain (Wu et al., [@B83]).

SKP1/CUL1/F-box protein (SCF) complexes are multi-subunit RING-type E3 ubiquitin ligases (Schulman et al., [@B69]). The F-box proteins provide specificity for ubiquitination by directly binding the target proteins. Pathogenic bacteria encode numerous F-box proteins; examples include *Agrobacterium tumefaciens* VirF, *Ralstonia solanacearum* GALA proteins, and proteins from other plant pathogens and human pathogens, including *Coxiella burnetii* and *L. pneumophila* (Chen et al., [@B9]; Price and Abu Kwaik, [@B61]).

Recent structural studies revealed a new family of E3 ligases, termed novel E3 ligases (NELs), which are conserved in bacteria and are distinct from both the RING and the HECT-type ligases (Hicks and Galan, [@B35]). The NEL E3 ubiquitin ligases include IpaH proteins from *Shigella* spp. (Singer et al., [@B72]; Zhu et al., [@B89]), and SspH1 and SspH2 from *Salmonella* spp. (Rohde et al., [@B64]; Quezada et al., [@B63]; Levin et al., [@B47]). IpaH9.8, a *Shigella flexneri* effector, is a NEL-type E3 ubiquitin ligase (Rohde et al., [@B64]) that promotes polyubiquitination and the subsequent proteasome-dependent degradation of the NFκB essential modifier (NEMO), which influences NFκB activation (Ashida et al., [@B5]).

The *P. syringe* effector HopM1 is thought to belong to an E3 ubiquitin ligase complex as an adaptor protein. Even without classical E3 ligase features, it mediates ubiquitination and the proteasome-dependent elimination of host AtMIN7, a plant protein involved in host defense (Nomura et al., [@B56]).

Temporal Regulation by a Metaeffector: *Legionella* LubX and SidH
=================================================================

*Legionella* effector proteins
------------------------------

*Legionella pneumophila* is a Gram-negative bacterium ubiquitously found in freshwater environments (Fields, [@B15]). *L. pneumophila* is able to replicate in a wide range of eukaryotic host cells, from free-living amoeba to human macrophages. Human infection can result in a severe pneumonia called Legionnaires' disease (Fields et al., [@B16]). The pathogenesis of *Legionella* is associated with intracellular replication of the bacteria. To replicate within phagocytic cells and to establish infection, *L. pneumophila* delivers numerous effector proteins (Ninio and Roy, [@B55]; Ensminger and Isberg, [@B14]; Franco et al., [@B20]; Isberg et al., [@B40]; Hubber and Roy, [@B38]; Zhu et al., [@B88]) via specialized protein transport machinery, the Dot/Icm type IV secretion system (T4SS; Segal et al., [@B70]; Vogel et al., [@B81]). Through the function of the effector proteins, *L. pneumophila* remodels the *Legionella*-containing phagosome to form a replicative compartment (Horwitz, [@B37]; Swanson and Isberg, [@B77]; Tilney et al., [@B80]). Effector proteins also modulate various host cellular functions for bacterial benefit and host cell survival, avoiding host immune responses, and bacterial egress (Shin and Roy, [@B71]).

It has been demonstrated experimentally that *L. pneumophila* translocates approximately 150 effector proteins via the Dot/Icm T4SS. The growing list of potential *L. pneumophila* effectors includes a significant number of proteins that share regions of similarity to eukaryotic protein domains or motifs (Franco et al., [@B20]; Isberg et al., [@B40]). One example is LubX, which possesses two U-box domains, conserved among U-box-type E3 ubiquitin ligases (Kubori et al., [@B44]). The U-box1 of LubX has E2 binding activity critical to the ligase function, while U-box2 serves as a substrate binding site. U-box2 binds to host Cdc2-like kinase 1 (Clk1; Kubori et al., [@B44]), as well as to another bacterial effector, SidH (Kubori et al., [@B45]), resulting in the polyubiquitination of these proteins in infected cells. Although the consequence of Clk1 ubiquitination is still being determined, polyubiquitinated SidH was shown to be subjected to proteasome-mediated protein degradation as described below.

Metaeffector: an effector regulating another effector
-----------------------------------------------------

The product of *sidH*, located just downstream of *lubX*, was translocated into the host cell cytosol and the cellular level of SidH was increased by the disruption of *lubX* (Kubori et al., [@B45]; Figure [1](#F1){ref-type="fig"}A). SidH was reported to be a *Legionella* Dot/Icm T4SS substrate (Luo and Isberg, [@B50]; Laguna et al., [@B46]), but its cellular function has not been clarified. LubX showed the ability to mediate polyubiquitination of SidH *in vitro* and *in vivo* (Kubori et al., [@B45]). In host cells polyubiquitinated SidH was shown to be subjected to proteasome-mediated protein degradation, as higher molecular weight species of SidH were observed in cells treated with the proteasome inhibitor MG132, but not in untreated cells (Figure [1](#F1){ref-type="fig"}A).

![**The *Legionella* "metaeffector" LubX temporally regulates SidH**. **(A)** LubX is responsible for polyubiquitination and proteasomal degradation of SidH in infected cells. CHO-FcR cells were infected with a wild-type *L. pneumophila* strain and a *lubX* deletion mutant for 8 h and the cell lysate was analyzed by immunoprecipitation, followed by western immunoblotting to detect SidH. The cells infected with the *lubX* deletion mutant, but not the wild-type strain, possessed an intact SidH protein. In the presence of a proteasome inhibitor, MG132, polyubiquitinated species of SidH were detected only after infection with the wild-type strain. This panel is reproduced from Kubori et al. ([@B45]) under the Creative Common Attribution License. **(B)** Time course of the relative amounts of SidH and LubX in the cells infected with the wild-type *L. pneumophila* strain. **(C)** A model of the temporal regulation of SidH. SidH is delivered via *Legionella* T4SS just after infection (left panel). Compared with SidH, LubX synthesis, and delivery is delayed. SidH is polyubiquitinated by the LubX ubiquitin ligase (middle panel), which leads to degradation of SidH by the host proteasome (middle and right panels). This panel is adopted from Kubori et al. ([@B45]).](fmicb-02-00145-g001){#F1}

The time course of SidH and LubX levels in infected CHO-FcR cells was analyzed (Figure [1](#F1){ref-type="fig"}B). SidH is expressed in culture-grown bacteria and is ready for delivery upon infection, while LubX expression is induced upon infection of host cells (Kubori et al., [@B44], [@B45]). SidH was detected in host cells immediately after infection and the level gradually decreased over time. LubX was not detected initially, but became detectable in a few hours with level peaking at 8 h after infection. The distinct time frames for protein expression/delivery lead to the temporal accumulation of SidH, which is eventually degraded by the host proteasome that is induced by polyubiquitination mediated by LubX (Figure [1](#F1){ref-type="fig"}C).

SidH is an intrinsically stable effector protein within the host cytosol and its function is deactivated at later stage of infection by LubX-mediated proteasomal degradation. LubX is a "metaeffector," a designation for an effector protein which regulates another effector protein (Kubori et al., [@B45]). In a fly infection model, an *L. pneumophila* strain lacking *lubX* showed hyper lethality to flies, suggesting that the persistent presence of SidH is harmful to the model host. In summary, the regulatory circuit involving the metaeffector LubX eliminates excess SidH at a later stage of infection, which would be beneficial for *Legionella*.

Temporal Regulation by Differential Stability: *Salmonella* SopE and SptP
=========================================================================

Bacterial internalization requires the function of SopE and SptP
----------------------------------------------------------------

*Salmonella* Typhimurium has the ability to invade non-phagocytic cells. The process of internalization of *Salmonella* into the intestinal epithelium was carefully described more than 40 years ago (Takeuchi, [@B78]). Electron microscopic observations revealed that *Salmonella* induced pronounced changes in the plasma membrane, disrupting microvilli, and entering intestinal epithelial cells by converting the bacterium-containing cavity into a membrane-bound vacuole. Importantly, the disrupted brush border was reconstituted even in the presence of internalized bacteria, showing the reversibility of the morphology of the plasma membrane according to the infection stage.

![**Coordination of the functions of SopE and SptP**. A model for the temporal regulation of SopE and SptP functions. SopE and SptP are delivered in equivalent amounts via the *Salmonella* T3SS upon infection, and SopE dominantly activates Rho GTPases Cdc42 and Rac as a GEF (left panel), resulting in bacterial uptake by profuse membrane ruffling (middle panel). Shortly after infection, SopE is polyubiquitinated in the cell and subjected to host proteasomal degradation (middle panel), making SptP dominant in the later stages of infection. SptP functions to shut off membrane ruffling by its GAP activity against Cdc42 and Rac, and normal cellular architecture is regained (right panel). This figure is adopted from Kubori and Galan ([@B43]).](fmicb-02-00145-g002){#F2}

Internalization of *Salmonella* into non-phagocytic cells is the result of marked actin cytoskeleton rearrangements that cause drastic changes in the plasma membrane of infected cells, which resemble "membrane ruffles" induced by growth factors, hormones, and activated oncogenes (Finlay et al., [@B18]; Ginocchio et al., [@B26]; Francis et al., [@B19]). The function of the Rho family GTPases is central to the cellular responses leading to actin cytoskeleton rearrangements, as well as to the nuclear responses upon infection with *Salmonella* (Chen et al., [@B10]). The formation of membrane ruffles upon *Salmonella* infection results from the coordinated action of *Salmonella* effectors delivered by the type III secretion system (T3SS; Patel et al., [@B59]). SopE and its homolog SopE2 are responsible for activating the Rho family GTPases Cdc42 and Rac1 via the function of GEF (Hardt et al., [@B30]; Rudolph et al., [@B66]; Bakshi et al., [@B7]; Stender et al., [@B76]). Another effector, SopB (also known as SigD), a phosphoinositide phosphatase, is also involved in the process of actin remodeling and bacterial uptake into cells, but has no guanine nucleotide exchange activity (Zhou et al., [@B86]). Other bacterial proteins, SipA and SipC, are known to be involved in efficient *Salmonella* entry by directly binding actin to modulate actin dynamics. SipC, an integral component of the T3SS translocon, is inserted into host plasma membranes (Scherer et al., [@B68]) and confers nucleation of actin polymerization and actin bundling (Hayward and Koronakis, [@B31]). SipA preferentially associates with peripheral cortical actin filaments (Higashide et al., [@B36]) and induces actin bundling, as well as preventing F-actin depolymerization (Zhou et al., [@B87]; Lilic et al., [@B48]; Dai et al., [@B12]). SipA substantially stimulates SipC-mediated nucleation of actin polymerization and actin bundling, demonstrating the cooperative action of these two effectors (McGhie et al., [@B53]). A *Salmonella* strain defective in SopE, SopE2, and SopB is, however, unable to induce actin rearrangement and fails to be internalized into host cells (Zhou et al., [@B86]), indicating that these three proteins are primary effectors responsible for *Salmonella* entry.

The process of restoring cellular morphology at a later stage of infection is dependent on the action of another effector, SptP (Fu and Galan, [@B22]). The amino-terminal domain of SptP possesses GAP activity toward Cdc42 and Rac1. SptP switches the regulatory molecules to an inactive GDP-bound state, resulting in disruption of the actin cytoskeleton, thus shutting off membrane ruffling (Fu and Galan, [@B21], [@B22]). *Salmonella* uptake is established by morphological changes in host cell membranes, induced by the reversible temporal activation of the Rho family GTPases.

![**Ubiquitin-mediated regulation of SopB localization**. Just after contact with host cells, *Salmonella* delivers SopB via the T3SS. SopB inositol phosphatase activity plays key roles in bacterial internalization and SCV maturation by inducing macropinocytosis accompanied by bacterial uptake. At the early stages of infection, SopB localizes to the plasma membrane and activates the protein kinase Akt. SopB also activates SGEF, a RhoG GEF, and indirectly activates Cdc42 (left panel), resulting in actin cytoskeleton reorganization to form "membrane ruffles" which enable bacteria to be internalized into host cells (middle panel). SopB is monoubiquitinated by the function of an unknown host ubiquitin ligase, and ubiquitinated SopB is then removed from the plasma membrane and recruited to the SCV, where SopB functions to modulate vesicular trafficking by altering phosphoinositide metabolism (right panel). This figure is adopted from Patel et al. ([@B58]).](fmicb-02-00145-g003){#F3}

Differential stability of SopE and SptP accounts for transient induction of membrane ruffling
---------------------------------------------------------------------------------------------

SopE and SptP represent a remarkable "yin and yang," displaying opposing functions in the same molecules. The mechanism determining the balance between these two effectors was examined in *sopE2*- and *sopB*-defective strain backgrounds in which SopE was the sole inducer for actin remodeling (Kubori and Galan, [@B43]). SopE and SptP are co-delivered into host cells shortly after infection, but SopE is predominant at inducing membrane ruffling, leading to bacterial internalization (Figure [2](#F2){ref-type="fig"}). In host cells, both SopE and SptP are subjected to polyubiquitination and proteasomal degradation, but display different half-lives; SopE is rapidly degraded, while SptP exhibits much slower degradation kinetics (Figure [2](#F2){ref-type="fig"}). This difference in stability disrupts the balance between the functions of these two proteins. SptP dominates during the later stages of infection, allowing for the recovery of the normal cellular architecture (Figure [2](#F2){ref-type="fig"}). By chimeric analysis, the signals for ubiquitin modification to SopE and SptP were found to be located within the amino-terminal region of the two proteins (Kubori and Galan, [@B43]), which possibly includes the signaling domain for secretion/translocation, as suggested by structural and functional analyses (Fu and Galan, [@B21]; Hardt et al., [@B30]; Stebbins and Galan, [@B73], [@B74]; Buchwald et al., [@B8]). The fact that the degradation signal is encoded in the proteins means that bacteria can determine the fate of their own proteins, the process of which is mediated by host cellular systems.

*Salmonella* SopB: Spatial Regulation Mediated by Monoubiquitination
====================================================================

Multifunctional effector SopB
-----------------------------

*Salmonella* phosphoinositide phosphatase SopB mediates actin-dependent bacterial internalization, as described above (Figure [3](#F3){ref-type="fig"}; Zhou et al., [@B86]; Patel and Galan, [@B57]). SopB activates SH-3-containing guanine nucleotide exchange factor (SGEF), an exchange factor for RhoG, which leads to specific cellular responses including actin remodeling (Patel and Galan, [@B57]). SopB phosphatase function also contributes to actin remodeling via Cdc42 signaling, but the mechanism remains unclear (Patel and Galan, [@B57]). SopB is also required for the efficient intracellular replication of bacteria by modulating *Salmonella*-containing vacuole (SCV) trafficking by inducing macropinocytosis upon bacterial uptake (Hernandez et al., [@B32]). The inositol phosphatase activity of SopB is necessary to generate PtdIns(3)P-decorated SCVs, which serve as a spacious niche where *Salmonella* can reside and replicate (Figure [3](#F3){ref-type="fig"}). Furthermore, SopB activates the serine protein kinase Akt (Steele-Mortimer et al., [@B75]), although the underlying mechanism behind this is poorly understood.

Spatio-temporal regulation of SopB mediated monoubiquitination
--------------------------------------------------------------

Recent studies have shown that SopB is an effector protein whose function is spatio-temporally regulated in an ubiquitin-dependent manner (Knodler et al., [@B42]; Patel et al., [@B58]). Multiple lysine residues in SopB are monoubiquitinated and linked via the Lys-63 of ubiquitin in the cells, and the ubiquitinated SopB is persistently present for a long time after bacterial internalization (Knodler et al., [@B42]; Patel et al., [@B58]). Analyses using a ubiquitin-deficient SopB mutant (in which all lysine residues were substituted with glutamate or arginine) revealed that ubiquitination is not required for bacterial uptake, but plays a significant role in cellular localization of SopB (Knodler et al., [@B42]; Patel et al., [@B58]). Early in infection, SopB localizes to the plasma membrane to mediate bacterial entry and Akt activation. In the later stages of infection, SopB is translocated to SCVs depending on its ubiquitination (Figure [3](#F3){ref-type="fig"}). Ubiquitin-deficient SopB was found to persist at the plasma membrane and failed to shut off Akt activation (Knodler et al., [@B42]; Patel et al., [@B58]).

Conclusion and Perspectives
===========================

In this article, we have focused on *Legionella* and *Salmonella* effector proteins, which are subjected to ubiquitin-mediated temporal or spatial regulation, highlighting the sophisticated strategies adopted by pathogenic bacteria to precisely regulate cellular processes during infection using the host ubiquitin system. Of particular interest, *Legionella* LubX functions as a metaeffector that targets another effector protein, SidH, and temporally regulates its proteasome-mediated degradation. Recent evidence indicates that pathogenic bacteria possess numerous effector proteins involved in ubiquitination reactions. Such effector proteins may function as metaeffectors like *Legionella* LubX. Comprehensive elucidation of how bacteria use the host ubiquitin system may lead to important insights into the molecular basis of bacterial pathogenesis.
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